|
 |
NatrecorThis page contains recent news articles, when available, and an overview of Natrecor but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....programs and that drug makers collected hundreds of millions of dollars in reimbursements for unapproved uses of the cardiac medication, Natrecor. ... Newsinferno.com Justice eyes marketing at J&J, Forest - Nov 10, 2009 ...related primarily to the marketing of antipsychotic Risperdal, as well as the seizure drug Topamax and congestive heart failure remedy Natrecor. ... FiercePharma The Deadly Mamba as a Lifesaver - Oct 19, 2009 ...called nesiritide, a genetically engineered version of the body's own B-natriuretic peptide now marketed as Natrecor by Johnson & Johnson's Scios unit. ... Wall Street Journal NewCo News - Nov 4, 2009 ...brain natriuretic peptide (BNP) is marketed for heart failure by Johnson & Johnson subsidiary Scios Inc. under the trade name Natrecor (nesiritide). ... Therapeutics Daily (press release) (registration) 3 major studies point to risk of heart-failure drug Natrecor - Apr 19, 2005 By Steve Sternberg, USA TODAY. Researchers challenged the safety of the heart-failure drug Natrecor for the second time in two months, reporting it could ... USA Today Heart drug's usage causes concern among some doctors.(Natrecor) - Jul 12, 2005 Jul. 12--WASHINGTON -- Shortly after the Food and Drug Administration in 2001 approved the heart failure drug Natrecor for hospitalized patients, ... Free with registration - Boston Globe - AccessMyLibrary.com Scios to conduct safety study of Natrecor - Jun 1, 2006 By Theresa Agovino, AP Business Writer | June 1, 2006. NEW YORK --Scios Inc. announced on Thursday that it would spend more than $100 million to conduct a ... Boston Globe J&J heart failure drug Natrecor fails study - Mar 25, 2007 By Kim Dixon. NEW ORLEANS, March 25 (Reuters) - A large study of a controversial Johnson & Johnson (JNJ.N) heart-failure drug failed to prove it helps ... Reuters US Not Told of 2 Deaths During Study of Heart Drug - Jan 4, 2006 Five of those deaths were of people who had taken Natrecor. The two additional deaths raised the total to seven among Natrecor patients, although Scios said ... New York Times … drug curbed Firm warns doctors against unapproved uses of Natrecor - Aug 6, 2005 Its Natrecor marketing records were subpoenaed in July by federal ... Natrecor was approved by the FDA in 2001 for a type of acute congestive heart failure ... San Francisco Chronicle Johnson & Johnson faces US inquiry on marketing of heart drug - Jul 22, 2005 Natrecor also has provided a profit center for some cardiologists, ... About 80 percent of the patients receiving Natrecor are covered by Medicare. ... New York Times J&J's Scios Unit Gets Subpoena for Natrecor - Jul 20, 2005 Johnson & Johnson's (JNJ Quote) Scios division received a subpoena from the US attorney's office in Boston requesting more information related to a ... TheStreet.com - TheStreet.com (subscription) The Marketing Of a Tuneup For the Heart; Issues Arise as Drug's Use … - May 17, 2005 But the drug, Natrecor, made by the Scios unit of Johnson & Johnson, ... Many other doctors contend that much cheaper alternatives to Natrecor -- like ... New York Times J&J Gets Subpoenas Over Three Drugs - Mar 12, 2007 The drugs at issue are Risperdal, a treatment for schizophrenia and bipolar mania, the epilepsy treatment Topamax, and Natrecor, which is used to treat ... FOXNews 1 in 4 new bio meds cause serious side effects - Oct 21, 2008 Included in the report released Tuesday were the arthritis drugs Humira and Remicade, cancer drugs Rituxan and Erbitux, and the heart failure drug Natrecor. ... msnbc.com … , NO BENEFIT SEEN FOR NATRECOR IN OUTPATIENT TREATMENTS - Mar 27, 2007 Natrecor, a synthetic version of a human hormone that dilates veins and ... Scios executives had maintained that 15 previous studies showed Natrecor poses ... $2.95 - San Jose Mercury News - NewsBank … Interim Report to FDA on NATRECOR(R)(nesiritide) PROACTION Trial. - Jan 3, 2006 FREMONT, Calif., Jan. 3 /PRNewswire-FirstCall/ -- Scios Inc. today announced it is submitting an interim report to the US Food & Drug Administration, ... Free with registration - PR Newswire - AccessMyLibrary.com A Growing Clamor over J&J's Natrecor - Oct 6, 2005 The furor over Johnson & Johnson's (JNJ ) controversial heart failure drug Natrecor shows no signs of abating. In a letter in the Oct. 6 issue of the New ... BusinessWeek New research: Heart drug Natrecor increases risk of death. | Article... - Sep 27, 2006 New research: Heart drug Natrecor increases risk of death. ... find San Jose Mercury News (San Jose, CA) articles. Byline: Steve Johnson Sep. Pay-Per-View - San Jose Mercury News - HighBeam Research Johnson & Johnson Lost A Blockbuster - Jun 14, 2005 NEW YORK - In the case of the embattled heart-failure drug Natrecor, ... While the trial is being conducted, the panel says Natrecor use should be curtailed ... Forbes … AT ISSUE - FDA SAYS GIFTS TO DOCTORS PROMOTING NATRECOR … - Nov 8, 2007 Natrecor, a synthetic version of a human hormone that dilates veins and arteries ... However, besides giving Natrecor to hospitalized patients, some doctors ... $2.95 - San Jose Mercury News - NewsBank J&J takes $440M charge on Natrecor - Nov 30, 2007 Here's a good estimate of how much it costs when a drug goes into free-fall: $440 million. That's how much Johnson & Johnson is writing off on Natrecor, ... FiercePharma J&J Posts Earnings Beat - Jan 22, 2008 ...and a $528 million charge for restructuring, in addition to a $441 million writedown related to congestive-heart failure therapy Natrecor. ... TheStreet.com - TheStreet.com (subscription) Expert Panel Gives Advice That Surprises a Drug Maker - Aug 9, 2005 After two medical studies questioned the safety of its popular heart failure therapy Natrecor, the Scios unit of Johnson & Johnson turned in April to a ... New York Times Natrecor Linked to Early Deaths in Acute Decompensated Heart Failure - Sep 26, 2006 By Neil Osterweil, Senior Associate Editor, MedPage Today. ANN ARBOR, Mich., Sept. 26 -- Natrecor (nesiritide) is associated with a significant increase in ... MedPage Today Cleveland Clinic may end use of J&J's Natrecor - May 4, 2005 Heart doctors at the Cleveland Clinic have voted unanimously to curtail or even ban the clinic's use of Johnson & Johnson's Natrecor after two recent ... Medical Marketing & Media - Medical Marketing and Media … - BUT FREMONT COMPANY SAYS NATRECOR SAFE, PLANS LARGE … - Sep 28, 2006 Those included 400 patients who took Natrecor -- also called nesiritide ... They found 31 of those taking Natrecor, or 7.8 percent, died within 30 days of ... $2.95 - San Jose Mercury News - NewsBank "Off-Label" Drugs: J&J Is Pushing The Envelope - Apr 25, 2005 By many accounts, longer-term use of Natrecor is growing. ... In a statement, Scios says it is marketing Natrecor according to its approved label. ... BusinessWeek Article: Study: Scios heart drug is safe. - San Jose Mercury News... - Mar 27, 2007 Natrecor, a synthetic version of a human hormone that dilates veins and arteries, ... Article: New research: Heart drug Natrecor increases risk of death. ... Pay-Per-View - San Jose Mercury News - HighBeam Research Tug-of-war over heart drug, Natrecor is a boon for many seriously ill... - May 24, 2005 An FDA official told Newsday the agency had been aware of Natrecor's potential to increase kidney dysfunction and raise the risk of mortality years ago when ... Pay-Per-View - Newsday - ProQuest Archiver … (DCRI) to Lead Landmark International Outcomes Trial of NATRECOR(R - Sep 7, 2006 The study will evaluate NATRECOR(R) administered at the currently ... NATRECOR(R) added to standard therapy is the only approved treatment for ADHF that has ... RedOrbit DDMAC to Scios: halt Natrecor promo.(DIRECT MARKETING) - Dec 1, 2007 THE FDA'S Division of Drug Marketing, Advertising and Communications (DDMAC) has told Johnson & Johnson's Scios unit to stop distributing promotional ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com Study Raises Concerns About J&J Drug - Mar 21, 2005 The mere chance of a risk may be cause for concern, because Natrecor is ... But it certainly supports the view that [Natrecor] should not be the first drug ... Forbes Natrecor Heart Drug - Deadly and Expensive - Mar 3, 2006 By Evelyn Pringle. Let there be no mistake, Johnson & Johnson, and its subsidiary Scois, knew all about the dangers associated with its heart failure drug ... scoop.co.nz Natrecor a Drag on Johnson & Johnson since Reports of Kidney Failure,... - Dec 6, 2007 Natrecor side effect reports have taken a toll on the finances of Johnson & Johnson. Natrecor was considered a potential hit in 2001 when the Food and Drug ... Newsinferno.com … New Renal, Mortality And Safety Data From NAPA Trial Of NATRECOR(R... - Sep 12, 2006 NATRECOR(R) is indicated for the intravenous treatment of patients with acutely ... There were no differences between the NATRECOR(R) and placebo groups in ... Medical News Today - Medical News Today (press release) Natrecor Authorized in Canada for Treatment of Acute Decompensated … - Nov 14, 2007 TORONTO, CANADA -- November 14, 2007 -- Health Canada has granted a Notice of Compliance with Conditions (NOC/c) for Natrecor* (nesiritide), ... DG News Loislaw Federal District Court Opinions - SCHAFFELD v. SCIOS, INC. ( … - Apr 10, 2008 Nesiritide is marketed and sold under the registered trademark name of Natrecor. Id. On April 1, 2002, Plaintiff was hired by Scios as a Cardiovascular ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Panel advise limited use of heart drug Natrecor - Jun 15, 2005 An independent panel of experts say heart-failure drug Natrecor should be restricted and only used with acutely ill hospitalized patients. ... News-Medical.net Scios to Conduct Safety Review of Heart Drug Natrecor - Jun 3, 2006 Scios Inc., a division of Johnson & Johnson, said Thursday that it would spend more than $100 million to conduct a safety study of its controversial ... HealthCentral.com NATRECOR Authorized In Canada For Treatment Of Acute … - Nov 15, 2007 Health Canada has granted a Notice of Compliance with Conditions (NOC/c) for NATRECOR* (nesiritide), for the treatment of hospitalized symptomatic Acute ... Medical News Today - Medical News Today (press release) Glaxo Drops European Rights To J&J Heart Drug - Jul 20, 2005 Natrecor is one of many drugs affected by a new focus on drug safety. Vioxx, from Merck (nyse: MRK - news - people ); Bextra, from Pfizer (nyse: PFE - news ... Forbes … Interim Report to FDA on NATRECOR(R)(nesiritide) PROACTION Trial. ... - Jan 3, 2006 Scios Submits Interim Report to FDA on NATRECOR(R)(nesiritide) PROACTION Trial. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … : No Role for Outpatient Nisiritide (Natrecor) in Decompensated... - Mar 27, 2007 By Peggy Peck, Managing Editor, MedPage Today. NEW ORLEANS, March 27 -- In the largest trial of stage D heart failure, nesiritide (Natrecor) showed no ... MedPage Today … International Outcomes Trial of NATRECOR(R) (nesiritide). - PR … - Jun 1, 2006 Scios Announces International Outcomes Trial of NATRECOR(R) (nesiritide). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research A Safety Question For J&J - Feb 14, 2005 But a few cardiologists are worried that Natrecor may harm the kidneys, ... Sackner-Bernstein's data indicate Natrecor increases the risk of kidney enzyme ... Forbes Protein Design Heart Drug Has Strong Chance To Succeed - Sep 6, 2005 The research firm said Ularitide will likely be held to more stringent standards as a result of the recent "controversy" regarding Natrecor, a heart drug ... Forbes … : BUT FREMONT COMPANY SAYS NATRECOR SAFE, PLANS LARGE … - Sep 28, 2006 Article: New research: Heart drug Natrecor increases risk of death. ... Nonetheless, Scios has been stung by criticism about Natrecor, which federal ... Pay-Per-View - San Jose Mercury News - HighBeam Research Scios Announces Recommended Use Initiative for NATRECOR(R) - Aug 22, 2005 FREMONT, Calif., Aug. 22 /PRNewswire/ -- Scios Inc. today announced it is launching a comprehensive recommended use initiative for NATRECOR(R) (nesiritide), ... RedOrbit Experts issue Natrecor warning, Specialists caution physicians about ... - Jun 16, 2005 A panel of heart specialists has recommended doctors proceed cautiously with the heart failure drug Natrecor, saying it should not be given to outpatients. ... Pay-Per-View - Newsday - ProQuest Archiver More Heartburn From J&J's Natrecor - Dec 3, 2007 By Brian Orelli. Johnson & Johnson (NYSE: JNJ) announced last week that it will take a noncash charge of $440 million from a writedown related to a decline ... fool.com PHARMACEUTICAL COMPANIES ARE UNDER FEDERAL SCRUTINY … - Oct 22, 2006 The heart-failure drug Natrecor seemed sure to become a blockbuster after ... There was only one problem: Some medical experts contend Natrecor was never ... $2.95 - San Jose Mercury News - NewsBank Article questions safety of J&J drug - Company defends its heart … - Mar 27, 2005 With the drug Natrecor, Johnson & Johnson found a way into the profitable ... Natrecor not only represented the first breakthrough treatment for acute heart ... Pay-Per-View - Star-Ledger - Factiva, from Dow Jones Atlanta health, diet and fitness news | ajc.com - Apr 25, 2005 The US Food and Drug Administration is ordering that more information about the risk of death from the heart failure drug nesiritide -- brand name Natrecor ... Atlanta Journal Constitution California and the West; J&J Limits Drug's Use - Aug 23, 2005 J&J's marketing of Natrecor, the subject of a federal subpoena in July, ... Johnson & Johnson is telling doctors to limit use of its Natrecor heart-failure ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Research Suggests Nesiritide Improves Postoperative Renal Function … - Feb 5, 2007 Natrecor®, added to standard therapy, is the only approved treatment for ... Natrecor® has been studied in 15 clinical trials involving 1407 patients ... DG News Article: Scios to Conduct Safety Study of Natrecor - AP Online |... - Jun 2, 2006 Scios to Conduct Safety Study of Natrecor ... find AP Online articles. THERESA AGOVINO, AP Business Writer AP Online 06-02-2006 Dateline: NEW YORK Scios ... Pay-Per-View - AP Online - HighBeam Research Heart Failure Drug Natrecor May Contribute to Renal Function Decline - Mar 22, 2005 By Neil Osterweil, Senior Associate Editor, MedPage Today. MANHASSET, NY-Natrecor (nesiritide), a potent vasodilator touted for acutely decompensated heart ... MedPage Today … Recommendations to Scios Regarding NATRECOR(R). - PR Newswi - Jun 14, 2005 Scios noted that the panel recommended a use for NATRECOR(R) that is slightly ... "The panel also described uses for which it believes NATRECOR(R) is ... Pay-Per-View - PR Newswire - HighBeam Research … Recommended Use Initiative for NATRECOR(R). - PR Newswire | … - Aug 22, 2005 Scios Announces Recommended Use Initiative for NATRECOR(R). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research J&J's Scios Launches Physician Education Program for Natrecor - Aug 24, 2005 In an apparent move to bolster its heart-failure treatment Natrecor, Johnson & Johnson's (J&J) Scios unit has launched a comprehensive physician education ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones Johnson & Johnson announces layoffs at two Bay Area firms: SCIOS,... - Jun 23, 2006 Although he said he didn't know which programs those were, he said the reductions would not affect Scios' drug Natrecor, a treatment for acute heart failure ... Free with registration - San Jose Mercury News - AccessMyLibrary.com … Experts Provides Recommendations to Scios Regarding NATRECOR(R). - Jun 14, 2005 Scios noted that the panel recommended a use for NATRECOR(R) that is slightly ... "The panel also described uses for which it believes NATRECOR(R) is ... $4.95 - PR Newswire - ECNext J&J asks doctors to limit Natrecor use - Sep 9, 2005 In an effort to curb off-label use of its heart failure drug Natrecor, Johnson & Johnson's Scios division has unveiled a new sales force education campaign ... Medical Marketing & Media - Medical Marketing and Media Schaffeld v. Scios, Inc., No. CV 07-0121-S-EJL-LMB (D.Idaho 04/10/2008... - Apr 10, 2008 Accordingly, the promotion of Natrecor for off-label issues is relevant to the ... At 6.7, 28 accounts purchase Natrecor, 4<100 vials, 24 < 60 vials YTD. ... $2.95 - U.S. District Court, District of Idaho - VersusLaw Study Supports Controversial Heart Failure Drug - Oct 29, 2007 Critics have charged that Natrecor, which costs about $500 a dose, ... The study found Natrecor to be safe when given to those patients it was developed ... Washington Post Scios subpoenaed over Natrecor.(Brief Article) - Aug 1, 2005 Johnson & Johnson subsidiary Scios says it has received a subpoena from the US Attorney's Office in Boston, Massachusetts, requesting documents relating to ... $4.95 - Pharma Marketletter - ECNext The Lure Of Off-Label - May 8, 2006 But some doctors say Scios pushed Natrecor for weekly "tune-ups," a use that ... A J&J news release boasted that weekly outpatient use of Natrecor "led to ... Forbes J&J's Scios reports new Natrecor deaths.(Brief Article) - Jan 9, 2006 Johnson & Johnson subsidiary Scios has submitted an interim report to the US Food & Drug Administration, and other relevant international regulatory ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Slumping Natrecor sales spur layoffs at Scios - Feb 23, 2006 With sales of its heart drug Natrecor hampered by reports of safety concerns, Johnson & Johnson announced that about 150 of Scios' 900 employees will ... FierceBiotech ALSO NOTED: Cleveland Clinic says Natrecor OK; Meridian Bioscience ' … - May 4, 2005 ...> Ohio's Meridian Bioscience, which mistakenly mailed a deadly flu virus to thousands of labs, did nothing wrong, CDC inspectors say. Story ... FierceHealthcare Press Release: The Cleveland Clinic Natrecor Recommendations of the (... - May 4, 2005 The Cleveland Clinic Natrecor Recommendations of the (Ad Hoc) Pharmacy and Therapeutics Committee. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research A Prescription For Trouble At J&J? - Apr 11, 2005 But despite J&J's public relations push, the Natrecor controversy is only ... Scios, the J&J unit that developed Natrecor, continues to insist it is safe. ... BusinessWeek Press Release: Scios Announces Enrollment of First Patients in ASCEND... - Jun 8, 2007 Article: Scios Announces FUSION 1 Study Shows Natrecor to be Safe ... ... Article: Scios to Present Five Natrecor Abstracts at 4th Annual ... ... Pay-Per-View - PR Newswire - HighBeam Research Expert Panel Advises Physicians on Natrecor Use - Jul 19, 2005 July 19, 2005 — The US Food and Drug Administration (FDA) and Scios have notified healthcare professionals via letter of recommendations made by a panel of ... Medscape PVH will administer Natrecor to some - Dec 14, 2005 POINT PLEASANT - A solution has been reached for at least one of the 11 heart patients at Pleasant Valley Hospital who had been left with no place to ... $2.95 - Point Pleasant Register - NewsBank The Cleveland Clinic Natrecor Recommendations of the (Ad Hoc) … - May 4, 2005 CLEVELAND, May 4 /PRNewswire/ -- The ad hoc committee of the Pharmacy and Therapeutics Committee at The Cleveland Clinic met today regarding the use of ... $4.95 - PR Newswire - ECNext Press Release: Scios Selects Duke Clinical Research Institute (DCRI)... - Sep 7, 2006 The study will evaluate NATRECOR(R) administered at the currently recommended dose ... Article: Scios Announces FUSION 1 Study Shows Natrecor to be Safe . ... Pay-Per-View - PR Newswire - HighBeam Research Scios Asks Leading Cardiologist to Convene External Panel of Experts... - Apr 12, 2005 ..."We are confident in the safety profile of NATRECOR(R) and the benefits it ... Thirteen company-sponsored clinical trials involving NATRECOR(R) have been ... RedOrbit Drug maker failed to disclose 2 deaths during tests | Article from … - Jan 5, 2006 Five of those deaths were of people who had taken Natrecor. ... Natrecor, which the U.S. drug regulator approved in August 2001 for use in acutely ill ... Pay-Per-View - International Herald Tribune - HighBeam Research Investigators Report Findings of a Phase 2 Pilot Study Evaluating … - May 9, 2006 NATRECOR(R) is indicated for the intravenous treatment of patients with acutely ... In this population, the use of NATRECOR(R) reduced pulmonary capillary ... Free with registration - PR Newswire - AccessMyLibrary.com Un quart des médicaments biologiques ont provoqué des effets … - Oct 22, 2008 ...notamment les anti-arthrites Humira et Remicade, les anti-cancéreux Rituxan et Erbitux et le traitement contre les défaillances cardiaques Natrecor. ... Romandie.com J&J's Natrecor: No Clinical Benefit - Mar 25, 2007 By Ed Silverman // March 25th, 2007 // 10:25 am. The heart-failure drug has been controversial for a couple of years and J&J's Scios unit has been under ... Pharmalot Scios Announces Enrollment of First Patients in ASCEND-HF Trial in … - Jun 8, 2007 NATRECOR(R) is the only approved treatment for ADHF that has shown ... NATRECOR(R) has been studied in 16 prospective clinical trials involving 2012 ... $4.95 - PR Newswire - ECNext … New Renal, Mortality and Safety Data From NAPA Trial of NATRECOR(R... - Sep 11, 2006 In addition, significantly fewer patients treated with NATRECOR(R) had a serum ... Article: Scios Announces FUSION 1 Study Shows Natrecor to be Safe ... ... Pay-Per-View - PR Newswire - HighBeam Research Nesiritide (Natrecor) for acute decompensated heart failure.(STEPS:... - Feb 15, 2006 Synopsis Safety Initial data from moderately sized controlled trials and large prospective registries suggested that nesiritide is safe. $4.95 - American Family Physician - ECNext Scios Launches Physician Education Program for Natrecor - Aug 29, 2005 Johnson & Johnson's (J&J) Scios unit has launched a comprehensive physician education program for its embattled heart-failure treatment Natrecor, ... Pay-Per-View - Washington Drug Letter - Factiva, from Dow Jones DDMAC to Scios: halt Natrecor promo.(DIRECT MARKETING) | Article … - Dec 1, 2007 DDMAC to Scios: halt Natrecor promo.(DIRECT MARKETING) ... find Medical Marketing & Media articles. THE FDA'S Division of Drug Marketing, Advertising and ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Press Release: Research Suggests Natrecor(R) (Nesiritide) Improves … - Feb 5, 2007 Research Suggests Natrecor(R) (Nesiritide) Improves Postoperative Renal Function and Potentially Enhances Survival After Coronary Artery Bypass Grafting. Pay-Per-View - PR Newswire - HighBeam Research Heart Beat; Follow-up: Limit Natrecor to hospital use, say experts.(Br... - Sep 1, 2005 An independent panel of experts took a hard look at the safety of Natrecor (nesiritide), a controversial heart failure drug, and how it is used during the ... Pay-Per-View - Harvard Heart Letter - Factiva, from Dow Jones US Attorney's Office Seeks Marketing Data on J&J's Natrecor - Jul 25, 2005 The US Attorney's Office in Boston is seeking additional information from Johnson & Johnson (J&J) about the firm's embattled heart-failure drug Natrecor. ... Pay-Per-View - Washington Drug Letter - Factiva, from Dow Jones Article: Heart Failure Drug Maker Relays New Deaths - AP Online | … - Jan 4, 2006 The manufacturer of the heart failure drug Natrecor reported two additional deaths in ... Article: Scios Files Amendment to Natrecor New Drug Application . ... Pay-Per-View - AP Online - HighBeam Research Editor's Choice: July 14, 2005 - Jul 14, 2005 In the Journal, Dr. Topol writes, "In my view, [Natrecor] has not yet met the ... Natrecor is the only approved treatment that has demonstrated proven ... Crain's Cleveland Business Article: FDA Orders Heart-Risk Info on Drugs - AP Online | HighBeam … - Apr 25, 2005 The expanded data on nesiritide, sold as Natrecor, includes findings from seven studies with ... Article: NARROW VOTE GIVES NOD TO NATRECOR FDA PANEL ... ... Pay-Per-View - AP Online - HighBeam Research Nesiritide limits postoperative renal dysfunction - May 12, 2006 Washington, DC - Perioperative infusion of nesiritide (Natrecor, Scios) apparently averted kidney damage in patients with chronic heart failure, ... Medscape Protein Design Labs makes strides in treating heart failure - Sep 7, 2005 Natrecor is being marketed by Johnson & Johnson's (NYSE:JNJ) Scios subsidiary in Fremont to treat heart failure, but its use has come under from some in the ... San Jose Business Journal - San Jose Business Journal (subscription) … CHATTER / NEW LABELING INFO REQUIRED FOR NATRECOR - May 2, 2005 The Food and Drug Administration is ordering that more information about the risk of death from a heart failure drug be added to the package insert for ... $2.95 - Press of Atlantic City, The - NewsBank The labeling for nesiritide (Natrecor, Scios) was revised. - May 1, 2005 The labeling for nesiritide (Natrecor, Scios) was revised to include data that 5.3% of patients receiving the agent in 7 studies died compared with 4.3% of ... $9.94 - Formulary - Alacra Store Drug giants miss mark - Oct 29, 2006 The heart-failure drug Natrecor seemed sure to become a blockbuster after ... There was only one problem: Some medical experts contend Natrecor was never ... $2.95 - San Mateo County Times - NewsBank Scios Announces Selection Of Independent Executive Committee And … - Nov 14, 2006 The trial's key efficacy objectives are to assess whether NATRECOR(R), ... NATRECOR(R) added to standard therapy is the only approved treatment for ADHF ... Medical News Today - Medical News Today (press release) Heart Failure Drug Maker Relays New Deaths | Article from AP Online |... - Jan 3, 2006 The manufacturer of the heart failure drug Natrecor reported two additional ... Natrecor was approved in 2001 to treat serious breathing problems that often ... Pay-Per-View - AP Online - HighBeam Research Off-Label Use of Blood Clotting Drug, NovoSeven, Linked to Deaths and... - Jan 19, 2006 In the case of Natrecor, nothing good can be said concerning the manner in which the ... Natrecor, or nesiritide, was approved by the FDA in 2001 to treat ... Newsinferno.com Scios Announces Results From Exploratory Nesiritide Study Providing … - Mar 25, 2007 NATRECOR(R) is the only FDA-approved intravenous treatment for patients with acutely ... Since NATRECOR(R) was approved by the FDA in August 2001, ... Free with registration - PR Newswire - AccessMyLibrary.com Heart Drug Maker Will Lay Off 150 - Feb 24, 2006 Natrecor was considered a potential blockbuster when the Food and Drug ... But Natrecor was also widely used to treat less severe heart failure, ... New York Times |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |